In finished products, this also creates a formulation concern: oxygen, heat, and carrier-oil quality can affect product stability
However, two recently completed phase III trials with one such inhibitor, darapladib, found that while this drug significantly reduced circulating PAF-AH activity, it had no effect on ASCVD events (426,427)
Read More Supplement Facts Serving Size: 1 Servings per Container: 20 * % Daily Value Other ingredients L-Carnitine Tartrate, Maltodextrin, Acidity Regulator (Citric Acid), Natural Orange Flavor, Anti-Caking Agent (Silicon Dioxide), Natural Lime Flavor, Sweeteners (Sucralose), Beetroot Concentrate, Color (Carotenes) Suitable for vegans Suitable for vegeterians EOF Notification Number: 90765/01.09.2023
(4) Warnings and Precautions Acute Pancreatitis: Has been observed in patients treated with GLP-1 receptor agonists, including BYETTA